SciELO - Scientific Electronic Library Online

 
vol.35 número4Tratamiento del cáncer de canal anal. Descripción de técnica y resultados de tratamiento radiante con o sin quimioterapia. Estudio retrospectivo en una población no seleccionada (1988 - 2016) índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Revista Médica del Uruguay

versión impresa ISSN 0303-3295versión On-line ISSN 1688-0390

Resumen

NOZAR, Fernanda; ROSSI, Emilia; BARBAJELATA, Ximena  y  GARCIA FONTE, Margarita. Study of the clinical use of positron emission tomography in the practice of oncological gynecology at the women’s hospital. Rev. Méd. Urug. [online]. 2019, vol.35, n.4, pp.4-28.  Epub 01-Dic-2019. ISSN 0303-3295.  https://doi.org/10.29193/rmu.35.4.1.

18 fluoro-2-deoxy-d-glucose (18FDG) PET (Positron Emission Tomography) is a diagnostic non- invasive nuclear medicine imaging technique, and it is usually associated to oncological pathologies.

Objective:

to assess the indication and impact of 18FDG PET in women with gynecologic cancer.

Study:

retrospective, descriptive study by reviewing the medical records of patients with gynecologic cancer who were seen at the Women’s Hospital. They underwent an 18FDG PET in the diagnostic assessment or follow-up between January 1, 2014 and December 31, 2017.

68 patients were studied, and 112 18FDG PETS were carried out. As to indication, in the case of cervical cancer (CC) most PET studies (51.5%) were used upon suspicion of relapse; in breast cancer to control evolution (44.6%); in endometrial cancer upon suspicion of relapse (50%); in ovarian cancer 37.5% upon suspicion of relapse and same percentage to control evolution; in vulvar cancer in the post-treatment follow-up or upon suspicion of relapse (50% each). As to global impact in the clinical practice, in the case of cervical cancer 60% of the studies resulted in modifications of the clinical behavior; in breast cancer this percentage was 49%; in endometrial cancer it was 43%, in ovarian cancer 50%, and vulvar cancer 50%.

18FDG PET is a technique that has been included in the gynecological clinical practice and guidelines for its use are still required.

Palabras clave : Positron-emission tomography; Genital neoplasms, female.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )